{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:54:03Z","timestamp":1768834443910,"version":"3.49.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"916","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Omeprazole is a potent proton pump inhibitor and usually is well tolerated. Adverse effects of this drug have been reported in up to 5% of patients, most of which are trivial and disappear rapidly on discontinuation of the drug. Skin adverse reactions attributed to omeprazole are uncommon and include rashes, urticaria, angio-oedema, acute disseminated epidermal necrolysis, lichen spinulosus, and contact dermatitis. Cutaneous leucocytoclastic vasculitis (CLV) has not been previously reported in association with omeprazole. The development of CLV in an elderly patient four weeks after starting treatment with omeprazole is described.<\/jats:p>","DOI":"10.1136\/pmj.78.916.114","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:29:07Z","timestamp":1027765747000},"page":"114-115","source":"Crossref","is-referenced-by-count":27,"title":["Cutaneous leucocytoclastic vasculitis associated with omeprazole"],"prefix":"10.1093","volume":"78","author":[{"given":"M","family":"Odeh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine B, Bnai Zion Medical Center, and Technion Faculty of Medicine, Israel Institute of Technology , Haifa , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lurie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Bnai Zion Medical Center, and Technion Faculty of Medicine, Israel Institute of Technology , Haifa , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Oliven","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Bnai Zion Medical Center, and Technion Faculty of Medicine, Israel Institute of Technology , Haifa , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,2,1]]},"reference":[{"key":"2023042416145666100_R1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM199104043241406","article-title":"Omeprazole","volume":"324","author":"Maton","year":"1991","journal-title":"N Engl J Med"},{"key":"2023042416145666100_R2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000200106","article-title":"Safety profile of omeprazole: adverse events with short-term treatment","volume":"44","author":"Nelis","year":"1989","journal-title":"Digestion"},{"key":"2023042416145666100_R3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0091-6749(96)70212-9","article-title":"Anaphylaxis to omeprazole","volume":"97","author":"Ottervanger","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"2023042416145666100_R4","first-page":"91A","article-title":"Clinical safety of omeprazole","volume":"3","author":"Solvell","year":"1989","journal-title":"Can J Gastroenterol"},{"key":"2023042416145666100_R5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0536.1986.tb01259.x","article-title":"Contact allergy to omeprazole","volume":"15","author":"Meding","year":"1986","journal-title":"Contact Dermatitis"},{"key":"2023042416145666100_R6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/bmj.305.6858.870-c","article-title":"Angio-oedema and urticaria associated with omeprazole","volume":"305","author":"Haeney","year":"1992","journal-title":"BMJ"},{"key":"2023042416145666100_R7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0025-7125(16)30630-7","article-title":"Cutaneous vasculitis: its relationship to systemic disease","volume":"37","author":"Swerlick","year":"1989","journal-title":"Med Clin North Am"},{"key":"2023042416145666100_R8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0025-6196(12)65016-2","article-title":"Cutaneous vasculitis: approach to diagnosis and systemic association","volume":"65","author":"Gibson","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"2023042416145666100_R9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/clinids\/20.4.1010","article-title":"Vasculitides associated with infection, immunization and antimicrobial drugs","volume":"20","author":"Somer","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2023042416145666100_R10","first-page":"347","article-title":"Rare adverse reactions to nonsteroidal antiinflammatory drugs","volume":"12","author":"O\u2019Brien","year":"1985","journal-title":"J Rheumatol"},{"key":"2023042416145666100_R11","first-page":"576","article-title":"Vasculitis caused by antithyroid drugs","volume":"104","author":"Verdy","year":"1975","journal-title":"Union Med Can"},{"key":"2023042416145666100_R12","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"2023042416145666100_R13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0002-9343(83)90419-9","article-title":"Cimetidine-induced vasculitis","volume":"75","author":"Michell","year":"1983","journal-title":"Am J Med"},{"key":"2023042416145666100_R14","first-page":"234","article-title":"Vasculitis leukocitoclastica y famotidina","volume":"95","author":"Andreo","year":"1990","journal-title":"Med Clin"},{"key":"2023042416145666100_R15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0002-9343(96)00356-7","article-title":"Leukocytoclastic vasculitis associated with nizatidine therapy","volume":"102","author":"Suh J-G, Oleksowicz","year":"1997","journal-title":"Am J Med"},{"key":"2023042416145666100_R16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/pgmj.61.713.245","article-title":"Amiodarone-induced vasculitis and polyserositis","volume":"61","author":"Staubli","year":"1985","journal-title":"Postgrad Med J"},{"key":"2023042416145666100_R17","first-page":"940","article-title":"Cutaneous vasculitis associated with amiodarone therapy","volume":"291","author":"Starke","year":"1985","journal-title":"BMJ"},{"key":"2023042416145666100_R18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5694\/j.1326-5377.1998.tb140224.x","article-title":"Proton pump inhibitors","volume":"169","author":"Katelaris","year":"1998","journal-title":"Med J Aust"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/78\/916\/114\/50039967\/postgradmedj-78-114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/78\/916\/114\/50039967\/postgradmedj-78-114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T16:15:56Z","timestamp":1682352956000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/78\/916\/114\/7038961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":18,"journal-issue":{"issue":"916","published-online":{"date-parts":[[2002,2,1]]},"published-print":{"date-parts":[[2002,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.78.916.114","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2002,2]]},"published":{"date-parts":[[2002,2,1]]}}}